MINDRAY MEDICAL MEXICO supplier risk profile Q1 2026—import trends, compliance flags, sourcing concentration analysis.
MINDRAY MEDICAL MEXICO received 85 shipments in Q1 2026 from just 2 suppliers across 2 countries, representing a highly concentrated sourcing model. Hong Kong accounted for 96.5% of shipments via MR HK, with the remainder sourced from KLM REMOTE LOCATION BARFIELD in the United States. The import portfolio spans 39 HS codes, with Chapter 90 (optical instruments and medical devices) dominating, evidenced by HS codes 901890 and 901812 each representing 12.9% of total shipments.
Trigram screen against OFAC SDN, BIS Entity List, UFLPA Entity List, SAM Exclusions, EU FSF, UK HMT, UN SC, and 25+ allied jurisdictions.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
MINDRAY MEDICAL MEXICO registered zero sanctions watchlist matches in Q1 2026. No suppliers in the identified supply chain registered forced-labor exposure under UFLPA proximity screening.
2 distinct tier-1 suppliers in Q1 2026
| MR HK | Hong Kong SAR China | 82 |
| KLM REMOTE LOCATION BARFIELD | United States | 3 |
Share of Q1 2026 inbound shipments by source country
2 tier-2 + 13 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.